Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eaueCfbwoceUekntpJGY

November 27, 2012
CONNECT WITH SMARTBRIEFFacebookTwitterBlog
Share|Sign up|Archive|Advertise
Agency Update 
Trends, Research & Stats 
  • A renewed focus on medication adherence
    Drugmakers lose approximately $188 billion yearly as patients fail to take prescribed treatments, according to the consultant Capgemini. "We need serious rethinking about what happens when medication is dispensed," said Kevin Volpp of the University of Pennsylvania's Center for Health Incentives and Behavioral Economics. Researchers and drug companies are experimenting with new approaches to boost adherence. Forbes (11/26) LinkedInFacebookTwitterGoogle+Email this Story
  • GSK to invest more in India and Nigeria
    GlaxoSmithKline announced plans to increase its share to 75% in India's GlaxoSmithKline Consumer Healthcare for about $940 million and to raise its stake to 80% in GlaxoSmithKline Consumer Nigeria for about $98 million. GSK owns 43.2% of the Indian unit and 46.4% of the Nigerian unit. Reuters (11/26) LinkedInFacebookTwitterGoogle+Email this Story
Interactive Ads & Technology 
  • Researchers study effect of social media health campaign
    A Facebook-based public health campaign intended to reduce teenagers' risky sexual behavior had only a small, short-term impact, but that impact reached a large number of teens, according to a study published in the American Journal of Preventative Medicine. About 10% of the teenagers who received newsfeed messages about sexual health posted comments and questions on the group's page. On follow-up, teens in the sexual health group self-reported slightly better rates of condom use while they were in the group, but rates fell after the messages stopped, researchers said. "It teaches us that you need to keep your content fresh," said lead researcher Sheana Bull. Salon/Pacific Standard (11/24) LinkedInFacebookTwitterGoogle+Email this Story
Go to Market Strategy 
Policy Pulse 
Featured Content 
 

Coalition News 
  • Recent OPDP enforcement letters target PR materials
    In a break from past practice, the FDA’s Office of Prescription Drug Promotion (OPDP) appears to be more closely scrutinizing drug companies’ public relations materials, as evidenced by two enforcement letters issued by OPDP last month citing a pitch letter and press releases. “Whether it’s a warning shot or a coincidence, it’s time for PR shops to brush up on the rules,” said Coalition for Healthcare Communication Executive Director John Kamp. Read more. LinkedInFacebookTwitterGoogle+Email this Story
Closing the Deal 
There is a crying need to get information out to doctors."
--Physician Alan Sandler, discussing speakers' bureaus, as quoted by The Oregonian
LinkedInFacebookTwitterGoogle+Email this Story


SmartBrief delivers need-to-know news in over 100 targeted email newsletters to over 3 million readers. All our industry briefings are FREE and open to everyone—sign up today!
Accounting
Advertising
Automotive
Aviation & Aerospace
Biotechnology
Business
Chemicals
Construction & Real Estate
Consumer Packaged Goods
Distribution
Education
Energy
Finance
Food Service
Health Care
Insurance
Legal
Manufacturing
Media & Entertainment
Nonprofit
Retail
Technology
Telecommunications
Travel & Hospitality
 

Subscriber Tools
SIGNUP SEND FEEDBACK E-MAIL THIS BRIEF
Today's Brief - Permalink | Print friendly format | Web version | Privacy policy

Advertise
Account Director:  Rebecca Adelson 202-618-5665
 
SmartBrief Community:
 
 
Recent SmartBrief for Health Care Marketers Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information